{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:11:55Z","timestamp":1793052715465,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cbi.2021.109617","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T03:36:34Z","timestamp":1628739394000},"page":"109617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT\/JAK\/MAPK pathways in streptozotocin-induced diabetic rats"],"prefix":"10.1016","volume":"347","author":[{"given":"Nora","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"AboGresha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal A.M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Z.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhan M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.cbi.2021.109617_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16162965","article-title":"SGLT2 inhibitors: a Review of their antidiabetic and cardioprotective effects","volume":"16","author":"Tentolouris","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"4","key":"10.1016\/j.cbi.2021.109617_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.cbi.2021.109617_bib3","first-page":"15537","article-title":"Exogenous spermine ameliorates high glucose-induced cardiomyocytic apoptosis via decreasing reactive oxygen species accumulation through inhibiting p38\/JNK and JAK2 pathways","volume":"8","author":"He","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"13","key":"10.1016\/j.cbi.2021.109617_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133299","article-title":"Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte","volume":"20","author":"Filardi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2021.109617_bib5","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1038\/s41598-019-51207-8","article-title":"Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study","volume":"9","author":"Fujita","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cbi.2021.109617_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00277-005-1102-9","article-title":"Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus","volume":"85","author":"Symeonidis","year":"2006","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.cbi.2021.109617_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1158\/1541-7786.MCR-09-0264","article-title":"Erythropoietin-induced activation of the JAK2\/STAT5, PI3K\/Akt, and Ras\/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line","volume":"8","author":"Shi","year":"2010","journal-title":"Mol. Canc. Res. : MCR"},{"issue":"4","key":"10.1016\/j.cbi.2021.109617_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cbi.2021.109617_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/dom.13923","article-title":"The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis","volume":"22","author":"Scholtes","year":"2020","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.cbi.2021.109617_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/abr.abr_8_17","article-title":"Novel high-fat diet formulation and streptozotocin treatment for induction of prediabetes and type 2 diabetes in rats","volume":"7","author":"Vatandoust","year":"2018","journal-title":"Adv. Biomed. Res."},{"issue":"3","key":"10.1016\/j.cbi.2021.109617_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/FJC.0000000000000557","article-title":"Cardioprotective mechanisms of exenatide in isoprenaline-induced myocardial infarction: novel effects on myocardial alpha-estrogen receptor expression and IGF-1\/IGF-2 system","volume":"71","author":"Darwesh","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"12","key":"10.1016\/j.cbi.2021.109617_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.echo.2009.08.014","article-title":"Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic cardiomyopathy in children and adolescents","volume":"22","author":"Menon","year":"2009","journal-title":"J. Am. Soc. Echocardiogr. : official publication of the American Society of Echocardiography"},{"issue":"3","key":"10.1016\/j.cbi.2021.109617_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.201101100","article-title":"The cell biology of disease: cellular mechanisms of cardiomyopathy","volume":"194","author":"Harvey","year":"2011","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.cbi.2021.109617_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00011-013-0625-0","article-title":"Interleukin-1beta induces a reversible cardiomyopathy in the mouse","volume":"62","author":"Van Tassell","year":"2013","journal-title":"Inflamm. Res. : official journal of the European Histamine Research Society [et al]"},{"issue":"12","key":"10.1016\/j.cbi.2021.109617_bib15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1046\/j.1540-8167.2004.04314.x","article-title":"Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography","volume":"15","author":"Koga","year":"2004","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"1","key":"10.1016\/j.cbi.2021.109617_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12933-018-0790-0","article-title":"A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats","volume":"17","author":"Durak","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.cbi.2021.109617_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-018-0745-5","article-title":"Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors","volume":"17","author":"Lahnwong","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cbi.2021.109617_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.cbi.2021.109617_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2021.109617_bib20","first-page":"1","article-title":"Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury","author":"Al-Ani","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.cbi.2021.109617_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41419-017-0093-5","article-title":"Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis","volume":"9","author":"Gu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2021.109617_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1475-2840-12-158","article-title":"Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy","volume":"12","author":"Liu","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"Pt 2","key":"10.1016\/j.cbi.2021.109617_bib23","doi-asserted-by":"crossref","first-page":"128547","DOI":"10.1016\/j.chemosphere.2020.128547","article-title":"Hexavalent chromium induced heart dysfunction via Sesn2-mediated impairment of mitochondrial function and energy supply","volume":"264","author":"Yang","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.cbi.2021.109617_bib24","doi-asserted-by":"crossref","first-page":"117319","DOI":"10.1016\/j.envpol.2021.117319","article-title":"Toxicological effects of deltamethrin on quail cerebrum: weakened antioxidant defense and enhanced apoptosis","volume":"286","author":"Li","year":"2021","journal-title":"Environ. Pollut."},{"issue":"1","key":"10.1016\/j.cbi.2021.109617_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12933-020-01066-9","article-title":"Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia\/reperfusion injury","volume":"19","author":"Lahnwong","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.cbi.2021.109617_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","article-title":"Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy","volume":"19","author":"Arow","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cbi.2021.109617_bib27","first-page":"354737","article-title":"Anemia in patients with type 2 diabetes mellitus","author":"Barbieri","year":"2015","journal-title":"Anemia 2015"},{"issue":"9888","key":"10.1016\/j.cbi.2021.109617_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"44","key":"10.1016\/j.cbi.2021.109617_bib29","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1093\/eurheartj\/ehaa890","article-title":"Management of chronic kidney disease and its cardiovascular complications: has the dawn of a new era arrived? Comment on 'Dapagliflozin in Patients with Chronic Kidney Disease","volume":"41","author":"Liuzzo","year":"2020","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.cbi.2021.109617_bib30","doi-asserted-by":"crossref","first-page":"F227","DOI":"10.1152\/ajprenal.00689.2014","article-title":"Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats","volume":"309","author":"O'Neill","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.cbi.2021.109617_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1179\/1743132813Y.0000000284","article-title":"Erythropoietin exerts cell protective effect by activating PI3K\/Akt and MAPK pathways in C6 Cells","volume":"36","author":"Kwon","year":"2014","journal-title":"Neurol. Res."},{"issue":"13","key":"10.1016\/j.cbi.2021.109617_bib32","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1074\/jbc.M208834200","article-title":"Activation of the mitogen-activated protein kinases Erk1\/2 by erythropoietin receptor via a G(i)protein beta gamma-subunit-initiated pathway","volume":"278","author":"Guillard","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cbi.2021.109617_bib33","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.cbi.2021.109617_bib34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/01.CIR.0000057545.82749.FF","article-title":"Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy","volume":"107","author":"Podewski","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cbi.2021.109617_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/jkst.20115","article-title":"Roles of STATs signaling in cardiovascular diseases","volume":"1","author":"Kishore","year":"2012","journal-title":"JAK-STAT"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:05:38Z","timestamp":1757858738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S0009279721002556"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109617","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT\/JAK\/MAPK pathways in streptozotocin-induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109617"}}